Lignans Market Analysis

Lignans Market Analysis

To get key market trends

  Download Free Sample

The Oil seeds-based segment will capture USD 107.11 billion and demonstrate a 5.9% CAGR by 2032. Oil seeds emerge as the dominant segment because flaxseeds, sesame seeds, and sunflower seeds dominate the market due to their high lignan content and bioavailability. These compounds are celebrated for their potential health benefits, notably their antioxidant and anti-inflammatory properties. The substantial market share of oil seeds is fueled by their prevalent use in food products, supplements, and nutraceuticals.
 

As consumer awareness of lignan-related health benefits grows, so does the demand for oil seeds. Additionally, technological advancements in extraction and processing have made it more efficient and cost-effective to derive lignans from these seeds. This trend not only cements the position of oil seeds in the lignans market but also underscores their pivotal role in the expansive health and wellness industry.
 

Cereals such as wheat, oats, rye, and barley are the primary sources of lignans. These compounds are commonly found in various food products, including couscous, macaroni, rice, bread, semolina pasta, Cheerios, muesli, oatmeal, Raisin Bran, compressed puffed rice, puffed barley, whole grain biscuits, and granola bars. As awareness of the importance of a balanced diet grows, so does the demand for cereal-based foods. These foods are appealing due to their low saturated fat content, cholesterol-free nature, and richness in carbohydrates, proteins, vitamins, minerals, antioxidants, and phytochemicals.
 

Such a beneficial composition helps protect against heart diseases, aids in weight management, and promotes better bowel health. Research indicates that Generation Z is increasingly adopting healthier eating habits. With the growing Generation Z population in countries like India, China, and the U.S., the demand for cereal-based foods is expected to rise, consequently boosting trends in the cereal-based lignans industry.
 

The Food segment held a 50% of the lignans market share in 2023, amounting to USD 15.19 billion, and is projected to grow at a 5.7% CAGR from 2024 to 2032. Lignans play a pivotal role in the production of various food items, such as pasta, cereals, whole grain breads, energy bars, crackers, snack foods, and meatless meal products. These lignans are incorporated into food products to bestow them with estrogenic and antioxidant properties.
 

Moreover, plant lignans found in high-fiber foods serve as precursors to mammalian lignans, which have been linked to a decreased risk of cardiovascular diseases and cancer. Given these benefits, the demand for lignan-infused products is expected to rise.
 

As lifestyle diseases like diabetes, high cholesterol, hypertension, obesity, and cardiovascular issues become more prevalent, consumers are increasingly leaning towards healthier diets. This shift in consumer preference is anticipated to bolster the demand for functional foods.
 

The Asia Pacific lignans market is projected to achieve USD 42.58 billion, with a CAGR of 5.4% from 2024 to 2032, driven by heightened consumer awareness of lignans' health benefits, including their potential to mitigate chronic disease risks and enhance overall wellness. Countries like China, Japan, and India are witnessing a pronounced shift towards natural and organic supplements, bolstering the region's dominance.
 

Furthermore, the burgeoning dietary supplement and functional food industries in Asia Pacific are propelling market growth. The region's strong agricultural sector underpins the supply chain for lignan-rich sources, notably flaxseeds and sesame. With rising disposable incomes and a pronounced shift towards healthier lifestyles, these elements collectively cement Asia Pacific's position at the forefront of the global lignans market.
 

According to market insights, Europe pharmaceutical industry is propelling at a faster rate owing to supportive government initiatives and rising novel product development by manufacturers. Initiatives including Priority Medicines initiative (PRIME) by European Medicines agency aiming to enhance development of medicines for unmet medical conditions should promote market growth.